Chemotargets and the CRG ally to accelerate the development of new treatments

by Centre for Genomic Regulation

​Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet ...

Read more

Oncoheroes Biosciences And Fundación Olivares: It Is Time For New And Better Therapies

by Oncoheroes Biosciences

Pediatric oncologists are forced to adjust adult cancer treatments for childhood cancer due to insufficient specific therapies for children with cancer.

Read more

The evolution of hepatitis C virus therapies

by IrsiCaixa

Dr Franco has presented in the online seminars of the College of Biologists of Catalonia new very effective treatments against hepatitis C, designed against three proteins essential for the replicatio...

Read more

ORYZON starts preclinical collaboration on autism with the Seaver Autism Center at Mount Sinai

by Oryzon Genomics

Goal is to explore effects of LSD1 inhibition on animal models of autism in Shank3 deficient mice models

Read more

SOM Biotech continues working during coronavirus outbreak to bring therapies for patients with rare diseases

by Som Biotech

While the coronavirus o​utbreak grows worldwide, at SOM Biotech we continue working on our pipeline to bring therapies for patients with rare diseases.

Read more

The health department will finance 3 IDIBELL’s projects on COVID-19

by Hospital Universitari de Bellvitge

The Department of Health, through the General Direction fo Research and Innovation in Health (DGRI) and in collaboration with Biocat, will finance with 4 million euros a total of 19 research and innov...

Read more

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels

by Hospital Universitari de Bellvitge

The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause

Read more

IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer

by IBEC - Institut de Bioenginyeria de Catalunya

The discovery is based on targeting the tissue surrounding the tumor, instead of the tumor directly

Read more

Oryzon announces First-Patients-in in CLEPSIDRA: a Phase IIa clinical trial with Iadademstat (ORY-1001) in Small Cell Lung Cancer patients

by Oryzon Genomics

Oryzon Genomics has announced today the inclusion of the first two p atient s in a Phase IIa clinical study with Iadademstat (ORY - 1001) in Small Cell Lung Cancer (SCLC) patients .

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream